Department of Surgical Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, 734-8551, Japan.
Breast Cancer Res Treat. 2014 Feb;144(1):59-69. doi: 10.1007/s10549-014-2859-0. Epub 2014 Feb 5.
Invasive lobular carcinoma (ILC) is more frequently lymph node positive than is invasive ductal carcinoma (IDC), and ILC cell infiltration shows distinctive histological characteristics, suggesting the action of ILC-specific invasion molecules. To identify such a molecule, we used a proteomic approach in the pseudopodia of MDA-MB-231 breast cancer cells. A pseudopodial constituent was identified using excimer laser ablation, two-dimensional difference gel electrophoresis, mass spectroscopy, and immunocytofluorescence. MDA-MB-231 cells were modified to express various levels of this constituent by transient transfection and were examined for pseudopodia formation and migratory abilities using wound healing and two-chamber assays. Immunohistochemical positivity of human breast cancer cells (56 ILCs and 21 IDCs) was compared with clinicopathological variables. An actin-binding adaptor protein, α-parvin, was found to localize to pseudopodia and to form focal adhesions in cells not induced to extend pseudopodia. Pseudopodial length and density and migratory abilities correlated with α-parvin expression. Twenty-one (37.5 %) ILCs stained positive for α-parvin, whereas the results were negative for all 21 IDCs (P < 0.001). α-Parvin positivity in ILC was significantly associated with lymphatic invasion (P = 0.038) and lymph node metastasis (P = 0.003) in univariate analyses and to lymph node metastasis (P = 0.020) in multivariate analyses. α-Parvin, a pseudopodial constituent, was found to promote migration of breast cancer cells and to be expressed exclusively by ILC, suggesting that α-parvin is an ILC-specific invasion molecule that may have clinical utility as a biomarker for aggressive subsets of ILC.
浸润性小叶癌 (ILC) 比浸润性导管癌 (IDC) 更常发生淋巴结转移,并且 ILC 细胞浸润具有独特的组织学特征,提示存在 ILC 特异性侵袭分子的作用。为了鉴定这种分子,我们使用 MDA-MB-231 乳腺癌细胞的伪足进行了蛋白质组学研究。使用准分子激光消融、二维差异凝胶电泳、质谱和免疫细胞荧光,鉴定了一个伪足成分。通过瞬时转染使 MDA-MB-231 细胞表达不同水平的该成分,并通过划痕愈合和双室测定法检查伪足形成和迁移能力。比较了人乳腺癌细胞(56 例 ILC 和 21 例 IDC)的免疫组织化学阳性与临床病理变量的关系。发现一种肌动蛋白结合衔接蛋白α-Parvin 定位于未诱导形成伪足的细胞中的伪足,并形成粘着斑。伪足长度和密度以及迁移能力与α-Parvin 表达相关。21 例(37.5%)ILC 对α-Parvin 染色阳性,而 21 例 IDC 均为阴性(P<0.001)。在单变量分析中,ILC 中α-Parvin 的阳性与淋巴管浸润(P=0.038)和淋巴结转移(P=0.003)显著相关,在多变量分析中与淋巴结转移(P=0.020)显著相关。α-Parvin 是一种伪足成分,可促进乳腺癌细胞的迁移,并且仅在 ILC 中表达,这表明α-Parvin 是一种 ILC 特异性侵袭分子,可能作为 ILC 侵袭性亚群的生物标志物具有临床应用价值。